AMGN

The 7 Most Undervalued Dow Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor
If you’re looking for the best deals among the most iconic enterprises, these are the most undervalued Dow stocks to buy.

Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts

By Shrey Dua, InvestorPlace Assistant News Writer
Wall street is buzzing over Amgen layoffs today. The biotech company announced it laid off 300 of its U.S. employees.

Dogs of the Dow 2023: 5 Dividend Stocks for Income Investors

By Prakash Kolli
The 2023 Dogs of the Dow feature several stocks investors should consider for their income portfolios. Here are the top five picks.

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

By Dana Blankenhorn, InvestorPlace Contributor
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

The 10 Best Dividend Stocks of All Time 

By Will Ashworth, InvestorPlace Contributor
The best dividend stocks of all time are some of the best-appreciating stocks over the past decade and should be on your watchlist in 2023.

The 7 Best Retirement Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff
Current bear market conditions present the perfect opportunity to invest in retirement stocks while they're trading at bargain valuations.

Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal

By Joel Baglole, InvestorPlace Contributor
HZNP stock is up on news that Horizon Therapeutics is being bought by Amgen in a friendly deal that's positive for both companies.

7 Christmas Stocks to Buy for Happy Holidays

By Louis Navellier and the InvestorPlace Research Staff
2022 took a toll on a lot of portfolios, leaving many investors feeling more like a Grinch than looking for Christmas stocks to buy.

7 Top-Tier Dividend Stocks to Buy for 2023

By Louis Navellier and the InvestorPlace Research Staff
You can find great top-tier dividend stocks in a variety of sectors. These are some of the best names you can buy heading into 2023.

7 Value Stocks That Are Too Cheap to Ignore

By Josh Enomoto, InvestorPlace Contributor
With market and economic forces eschewing growth-focused companies, now may be the time to consider cheap value stocks to buy.

The 7 Best Biotech Stocks to Buy

By Dana Blankenhorn, InvestorPlace Contributor
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.

Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment

By Dana Blankenhorn, InvestorPlace Contributor
Sotyktu's Phase 3 study showed it more effective than Amgen's Otezla for treating psoriasis.

7 Dow Stocks With Superior Fundamentals

By Tezcan Gecgil, InvestorPlace Contributor
While investors look for safe bets, here are seven Dow stocks to buy in September.

ChemoCentryx (CCXI) Stock Soars 100% on Amgen Acquisition

By William White, InvestorPlace Writer
ChemoCentryx (CCXI) stock is rocketing higher on Thursday as investors react to news of an acquisition deal with Amgen (AMGN).

7 Best Pharmaceutical Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.

3 Biotech Stocks Outperforming a Bear Market

By Jaimini Desai
These biotech stocks are the most attractive from a valuation and growth perspective as they are less impacted by a slowing economy or change in monetary policy.

7 Dividend Stocks to Buy for Your Grandkids

By Louis Navellier and the InvestorPlace Research Staff
If this roiling market is making you seasick, then it's an excellent time batten down the hatches with these reliable dividend stocks.

7 Retirement Stocks to Buy to Turbocharge Your Savings

By Chris Markoch, InvestorPlace Contributor
The best offense is a good defense. Here are seven retirement stocks to buy that combine modest growth with safe dividends.

7 Dividend Stocks to Boost Your Retirement Savings

By Louis Navellier and the InvestorPlace Research Staff
This is a very good time to look for quality foundational stocks that not only have growth potential but are solid dividend stocks, too.
Load More